Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
1
users have commented on this narrative
17
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
12
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Metropolis Healthcare
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Digital Testing Will Undermine Traditional Diagnostics Profitability
Key Takeaways Rapid advancements in digital and decentralized diagnostics, alongside intensified competition and regulatory scrutiny, threaten Metropolis Healthcare's market share, revenue growth, and pricing power. Aggressive expansion and consumer price sensitivity risk operational inefficiency, earnings volatility, and difficulty sustaining profitable long-term growth.
View narrative
₹1.66k
FV
29.5% overvalued
intrinsic discount
12.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
RHI Magnesita
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Price Competition And Overcapacity Will Erode Margins Yet Enable Recovery
Key Takeaways Aggressive price competition and global overcapacity are sustaining margin pressures and threatening top-line revenue growth despite strong long-term demand foundations. High costs, cyclical end-market exposure, and M&A integration risks challenge margin recovery and earnings stability, even as sustainability initiatives and geographic diversification advance.
View narrative
UK£28.86
FV
22.6% undervalued
intrinsic discount
2.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Youdao
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
China Demographics And Regulatory Hurdles Will Limit Expansion
Key Takeaways Long-term growth is challenged by demographic shifts, regulatory pressures, and heavy dependence on parent company support. Rapid hardware expansion and commoditization of AI services raise risks to margins, competitive positioning, and revenue stability.
View narrative
US$9.63
FV
5.6% undervalued
intrinsic discount
11.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Strides Pharma Science
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
US Market Dependency Will Strain Margins Yet Yield Opportunity
Key Takeaways Heavy reliance on the US market and supply chain risks could create earnings volatility and slow global expansion efforts. Intensifying competition, regulatory pressures, and shifting pharmaceutical trends may limit further margin gains and long-term growth potential.
View narrative
₹937.00
FV
7.2% undervalued
intrinsic discount
13.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Knowit
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Compliance And Competition Will Weaken Margins Though Efficiency Will Advance
Key Takeaways Margin improvement is constrained by rising compliance costs, wage inflation, and challenges differentiating from competitors, despite demand in cybersecurity and digital transformation. Execution risks from acquisitions and rapid AI adoption may limit benefits from growth initiatives, threatening future revenue streams and sustained earnings recovery.
View narrative
SEK 143.00
FV
18.9% undervalued
intrinsic discount
2.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Northam Platinum Holdings
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Rising EV Demand And Recycling Will Erode PGM Revenues
Key Takeaways Declining demand due to electric vehicle growth, recycling, and material substitution threatens long-term revenue and profitability for platinum group metals. High operating costs and concentrated South African assets expose the company to risks like regulatory, power, and labor disruptions, further pressuring margins.
View narrative
R130.00
FV
53.6% overvalued
intrinsic discount
15.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Macerich
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
E-commerce Trends Will Pressure Declining Mall Revenues
Key Takeaways Persistent shifts to e-commerce and changing consumer preferences threaten long-term leasing revenue and profitability, despite recent leasing gains and backfilling efforts. High leverage and exposure to underperforming malls increase refinancing risk, limit redevelopment capacity, and pressure future earnings and cash flow.
View narrative
US$15.00
FV
15.9% overvalued
intrinsic discount
-6.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
NV Bekaert
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Overcapacity And Tightening Regulations Will Suppress Industry Margins
Key Takeaways Declining demand for steel products, combined with slow innovation and digital lag, threatens future growth and risks losing market share to more agile competitors. Heightened regulatory costs, operational disruptions, and economic volatility expose margins and revenue to persistent uncertainty and increased risk across markets.
View narrative
€32.00
FV
21.3% overvalued
intrinsic discount
1.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Saturn Oil & Gas
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Debt In Western Canada Will Restrict Margins But Prompt Adjustment
Key Takeaways Saturn Oil & Gas faces financial constraints and regional risks that limit its ability to fully benefit from favorable energy market conditions. Ongoing capital needs, regulatory uncertainties, and competition from global producers threaten both operational stability and long-term earnings growth.
View narrative
CA$3.00
FV
16.7% undervalued
intrinsic discount
-3.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies